Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine...
Beckley Foundation
Mon, Apr 8
Background 3,4-Methylenedioxymethamphetamine (MDMA) is drug of high prevalence in Aotearoa New Zealand and is the primary drug analysed by legal drug checking services. We aimed to address the gap in...
Discover